Simplify Logo

Full-Time

Director – Project Management

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function improvement

Biotechnology
Healthcare

Compensation Overview

$216k - $264kAnnually

Expert

San Bruno, CA, USA

Category
Project Management
Business & Strategy
Required Skills
Power BI
Communications
Management
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree in a related field (Project Management, Business Administration, etc.) with 12+ years of experience in project management, specifically within the pharmaceutical industry
  • Proven expertise in project management methodologies, tools, and best practices, including MS Project, OnePager, Smartsheet, and PowerPoint
  • Demonstrated experience leading project management teams and study operating teams for Phase 2/3/4 clinical trials in late-stage development
  • Strong ability to influence and persuade stakeholders, driving consensus and facilitating decision-making processes in a collaborative manner
  • Exceptional communication, interpersonal, and leadership skills, essential for effectively communicating project objectives, strategies, and progress to stakeholders across all levels of the organization
  • PMP certification or equivalent is a plus
Responsibilities
  • Collaborate with Clinical Study Operating Team to monitor project progress, identify risks, and develop effective mitigation strategies to keep clinical trial on track
  • Facilitate and lead effective Product Strategy Team meetings, including the creation of effective meeting agendas and clear documentation of key issues for discussion, decisions made and assigned action items
  • Partner with Clinical Research and Commercial Product Strategy Team leaders to develop recommendations for risk mitigation, prioritization at quarterly Portfolio Review Committee meetings
  • Maintain project management processes, procedures, and best practices to streamline trial execution and ensure consistency across the entire R&D pipeline
  • Collaborate cross-functionally to support corporate initiatives, defining scopes, objectives, and deliverables in alignment with organizational goals
  • Develop and maintain comprehensive project plans, timelines, and budgets using tools such as excel, MS Project, OnePager, PowerBI, and Smartsheet

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.